Page last updated: 2024-08-21

oxazoles and atorvastatin

oxazoles has been researched along with atorvastatin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Aragoncillo, P; Cachofeiro, V; Cediel, E; de Las Heras, N; Díaz, C; Hernández, G; Lahera, V; Navarro-Cid, J; Ruilope, LM; Sanz-Rosa, D; Vázquez-Pérez, S	1
Guillard, R; Issandou, M; Venteclef, N	1
Foley-Comer, AJ; Jordan, P; Russell-Yarde, F; Young, AM	1
Han, L; Li, MG; Ye, P	1
Appelt-Menzel, A; Cubukova, A; Gohla, A; Haider, MS; Jeanclos, E; Kataoka, K; Kinoh, H; Krafft, M; Lübtow, MM; Luxenhofer, R; Meier, L; Oerter, S; Quader, S; Rist, M; Sampetrean, O; Schulte, C	1

Trials

1 trial(s) available for oxazoles and atorvastatin

Article	Year
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin. Expert opinion on investigational drugs, 2011, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Area Under Curve; Atorvastatin; Cross-Over Studies; Drug Interactions; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Thiophenes; Young Adult	2011

Article

Year

Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.

Expert opinion on investigational drugs, 2011, Volume: 20, Issue:1

Topics: Adolescent; Adult; Aged; Area Under Curve; Atorvastatin; Cross-Over Studies; Drug Interactions; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Thiophenes; Young Adult

2011

Other Studies

4 other study(ies) available for oxazoles and atorvastatin

Article	Year
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Acetylcholine; Animals; Anticholesteremic Agents; Atorvastatin; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hypercholesterolemia; Kidney; Male; Nitroprusside; Oxazoles; Phenylephrine; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Renal Circulation; Vasodilation	2001
The imidazoline-like drug S23515 affects lipid metabolism in hepatocyte by inhibiting the oxidosqualene: lanosterol cyclase activity. Biochemical pharmacology, 2005, Apr-01, Volume: 69, Issue:7 Topics: Animals; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Primers; Enzyme Inhibitors; Hepatocytes; Heptanoic Acids; Intramolecular Transferases; Kinetics; Lipid Metabolism; Liver Neoplasms; Oxazoles; Polymerase Chain Reaction; Pyrroles; Rats	2005
[The effect of PPARalpha signal channel on atorvastatin inhibiting MMP-9 expression in aging myocytes]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2013, Volume: 29, Issue:5 Topics: Aging; Animals; Atorvastatin; Cells, Cultured; Heptanoic Acids; Matrix Metalloproteinase 9; Muscle Cells; Oxazoles; PPAR alpha; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Tyrosine	2013
Molecular pharmaceutics, 2020, 06-01, Volume: 17, Issue:6 Topics: Antineoplastic Agents; Atorvastatin; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatography, High Pressure Liquid; Drug Compounding; Dynamic Light Scattering; Glioblastoma; Humans; Induced Pluripotent Stem Cells; Micelles; Nanomedicine; Neoplastic Stem Cells; Oxazoles	2020